Professor of Medicine and Genetics and Director of the Institute for Aging Research, Albert Einstein College of Medicine
Nir Barzilai is a chaired professor of medicine and genetics and the director of the Institute for Aging Research at the Albert Einstein College of Medicine, which is currently the biggest center in the world to study the biology of aging. This institute is the home of the Nathan Shock Center of Excellence in the Biology of Aging and the Paul F. Glenn Center for the Biology of Human Aging. He is the recipient of an NIH Merit Award for aiming to extend the healthy life span in rodents by biological interventions. He also studies families of Ashkenazi Jewish centenarians, which has provided genetic/biological insights on the protection against aging. Several drugs are developed based, in part, on these paradigm-changing studies. He is a recipient of numerous prestigious awards, including the 2010 Irving S. Wright Award of Distinction in aging research. Dr. Barzilai is in the board of the American Federation for Aging Research, is its co-scientific director, and has served on several NIA study sections. He is also a founder of CohBar Inc., a biotechnology company developing mitochondria-based therapeutics to treat diseases associated with aging.